MedTrace Logo

Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices

NCT03366545 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3030

Last updated 2026-02-12

No results posted yet for this study

Summary

The registry is primarily designed to assess outcome, efficacy and residual safety aspects of CRT based on long-term data from an unselected, real-life clinical set-up. Moreover, the observation of the patient status should help to find possible predictors for HF events and to identify areas of improvement for CRT and for CRT device settings.

Conditions

Interventions

DEVICE

Cardiac Resynchronization Therapy (CRT)

Observation and documentation of routine care for CRT patients

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-14
Primary Completion
2025-09-22
Completion
2026-06-30

Countries

  • Australia
  • Austria
  • Belgium
  • Czechia
  • France
  • Germany
  • Hungary
  • Israel
  • Italy
  • Japan
  • Latvia
  • Poland
  • Portugal
  • Singapore
  • Slovakia
  • South Africa
  • Spain
  • Switzerland
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03366545 on ClinicalTrials.gov